Lena Willkomm is currently the Global Clinical Program Excellence Lead at Bayer Pharmaceuticals, a position they have held since 2024. Previously, they served as a Global Program Manager at Bayer Pharmaceuticals from 2020 to 2024 and as a Research Scientist. Lena completed a postdoctoral researcher role at Uniklinik Köln from 2014 to 2015 and held a research position at Deutsche Sporthochschule Köln in 2006-2007. They earned a Bachelor of Science in Molecular Medicine from Georg-August-Universität Göttingen, a Master of Science from the University of Glasgow, and a Dr. nat. med. in Molecular Medicine from Universität zu Köln.
Location
Cologne, Germany
This person is not in the org chart
This person is not in any teams
This person is not in any offices